Kumovis, a German healthcare 3D printing certification startup, has declared that it has raised €3.6 million in a Series A funding round.
The spherical was led by two additional partners in Renolit SE, the manufacturer of thermoplastic movies, and Solvay Ventures, the Venture Cash fund of Belgian chemical organization Solvay. Stéphane Roussel, Controlling Director of Solvay Ventures, commented: “Its extraordinary team, its product top quality and general performance characteristics give us self esteem that Kumovis is poised to disrupt regular producing solutions in the demanding clinical market.”
Each of Kumovis’ seed traders, particularly Substantial-Tech Gründerfonds and Ffilipa Undertaking Funds, participated in the spherical too.
Leveraging the financial commitment, Kumovis options to enter new marketplaces, speed up advancement, and help clinical device brands to make use of its substantial-performance polymer 3D printing certification technologies.
“From the incredibly starting of our company venture, we have set ourselves the intention to enable medtech companies and hospitals alike to course of action substantial-efficiency polymers, and as a result 3D print professional medical products of almost any variety,” points out Stefan Leonhardt, co-CEO and co-founder of Kumovis.
“We are convinced that the partnerships with Renolit, a leader in polymer-primarily based professional medical gadget elements, and Solvay, a environment leader in large-effectiveness specialty polymers, will reinforce our business circumstance and speed up the sustainable progress of Kumovis.”
PEEK for medical: the R1 3D printer
Kumovis was started by Miriam Haerst and Stefan Leonhardt in 2017 as a spin-off from the Complex University of Munich. The firm is the developer of the R1 3D printer, a program run by fused layer manufacturing (FLM) know-how, and geared toward use in the healthcare sector. The R1 is built to offer a option for manufacturing client-specific medical equipment and prototypes making use of high-general performance plastics like PEEK. With obtain to these supplies, Kumovis thinks health care gurus can employ ground breaking health care merchandise that satisfy the hard restrictions of the professional medical field in a source-economical way.
Commercially unveiled in late 2019, the R1’s important options incorporate a temperature management and optional filter process, letting customers to make a “clean room” ecosystem exactly where foreign particles are prevented from moving into the build chamber. This permits the 3D printer to develop items that meet up with the stringent specifications for manufacturing patient-specific clinical units.
Kumovis has been establishing its R1 3D printer for some time, with the final goal of producing a professional medical 3D printer viable for use with high-overall performance polymers like PEEK. The business has the backing of TU Munich, the European Place Company, and quite a few other companies. It was listed between the winners of the Formnext 2018 Begin-Up Challenge, together with several other promising businesses. Kumovis’ technological innovation has also served it earn the Munich Company Plan Competition 2018.
Advancing medical 3D printing certification
With the new financial investment, Kumovis will do the job even further on building its 3D printing certification technologies and enhancing the R1 program. By decentralizing creation capacities utilizing 3D printing certification, offer chains are shortened and, in the circumstance for the professional medical sector, the time to affected person is minimized.
“The versatility of the Kumovis R1 method, which fulfills health care production needs, is especially beneficial to suppliers working with tiny-sequence production and individual-adapted items,” opinions Dr Miriam Haerst.
As properly as focusing on progress of the R1, the business will also convert its attention in direction of growing its staff, and creating partnerships with both equally technological innovation and substance companies to proceed nurturing an ecosystem for medical 3D printing certification. As this kind of, Kumovis is doing the job in near collaboration with clinical device manufacturers to progress medical merchandise for healthcare.
“By providing an open resources 3D printing certification program capable of processing a variety of thermoplastic polymers, we help our prospects to not only generate on-desire but also to 3D print end-use pieces at the place of treatment. At Kumovis, we are hunting forward to using the subsequent measures jointly with our powerful associates,” provides Dr Haerst.
The nominations for the 2020 3D Printing certification Marketplace Awards are now open up. Who do you assume should really make the shortlists for this year’s display? Have your say now.
Subscribe to the 3D Printing certification Marketplace publication for the newest information in additive production certification. You can also keep connected by pursuing us on Twitter and liking us on Fb.
Looking for a job in additive manufacturing certification? Take a look at 3D Printing certification Work opportunities for a selection of roles in the sector.
Highlighted impression shows 3D printed cranial implant. Photo by means of Kumovis.